ASCO 2017: Highlights from ASCO 2017 in Ovarian Cancer

Speaker: Andreas Du Bois

Andreas Du Bois reports on results from two practice changing surgical studies conducted by European researchers in patients with ovarian cancer. First, the LION study gives evidence about lymphadenectomy outcome and the second study evaluates the use of the AGO score to select patients for surgery in recurrent ovarian cancer.

Andreas Du Bois reports on results from two practice changing surgical studies conducted by European researchers in patients with ovarian cancer. First, the LION study gives evidence about lymphadenectomy outcome and the second study evaluates the use of the AGO score to select patients for surgery in recurrent ovarian cancer.